A new gene editing tool that helps cellular machinery skip parts of genes responsible for diseases has been applied to reduce ...

Within the human digestive tract are trillions of bacteria from thousands of different species. These bacteria form ...

Genomics companies analyze and interpret genetic information to uncover insights about genetic variations and disease ...

UiB researchers are behind a new discovery that tells us how associated neurodegenerative diseases might develop.

The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients ...

Wilmington Savings Fund Society FSB bought a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 3rd ...

This study provides important insights into the regulation of a retained intron in the mRNA coding for OGT, a process known to be regulated by the O-GlcNAc cycling system, and highlights the ...

CRISPR Therapeutics' approved medicine could benefit from government coverage in the U.S. This is a good sign for the biotech ...

Stifel Financial Corp cut its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 20.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 40,237 ...

CRISPR Therapeutics的股票有许多值得投资的理由。从其首个商业化疗法的良好推出到一条前景看好的管线，这家生物科技公司正处于增长轨道。此外，投资者最近又获得了一个重大的投资信号。

In the simulation hypothesis, some scientists believe we could outsmart the simulator—even in the unlikely case we’re just ...